Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Stepanova

Showing results (31-40 of 242) with videos related to

Pageof 25
Sort By:
Biophysical Journal|November 13, 2007
Conformational analysis of the carboxy-terminal tails of human beta-tubulin isotypesTyler Luchko, J Torin Huzil, Maria Stepanova, et al.
Plos One|November 24, 2011
Effects of temperature on the p53-DNA binding interactions and their dynamical behavior: comparing the wild type to the R248Q mutantKhaled Barakat, Bilkiss B Issack, Maria Stepanova, et al.
JHEP Reports : Innovation in Hepatology|February 21, 2025
Validation of the Chronic Liver Disease Questionnaire for MASH (CLDQ-MASH)Zobair M Younossi, Maria Stepanova, Issah Younossi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 31, 2012
In-hospital mortality and economic burden associated with hepatic encephalopathy in the United States from 2005 to 2009Maria Stepanova, Alita Mishra, Chapy Venkatesan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 15, 2019
Validation of Chronic Liver Disease Questionnaire for Nonalcoholic Steatohepatitis in Patients With Biopsy-Proven Nonalcoholic SteatohepatitisZobair M Younossi, Maria Stepanova, Issah Younossi, et al.
Clinical and Translational Gastroenterology|May 13, 2024
Validation of a Primary Biliary Cholangitis-Specific Version of Chronic Liver Disease Questionnaire: CLDQ-PBCZobair M Younossi, Maria Stepanova, Issah Younossi, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 14, 2018
Prediction of Health Utility Scores in Patients with Chronic Hepatitis C Using the Chronic Liver Disease Questionnaire-Hepatitis C Version (CLDQ-HCV)Maria Stepanova, Issah Younossi, Andrei Racila, et al.
Journal of the American Geriatrics Society|January 31, 2016
Patient-Reported Outcomes of Elderly Adults with Chronic Hepatitis C Treated with Interferon- and Ribavirin-Free RegimensZobair M Younossi, Maria Stepanova, Fatema Nader, et al.
FEBS Open Bio|June 20, 2014
Molecular mechanisms in the selective basal activation of pyrabactin receptor 1: Comparative analysis of mutantsLyudmyla Dorosh, Nandhakishore Rajagopalan, Michele C Loewen, et al.
Digestive Diseases and Sciences|November 13, 2012
Anthropometric and clinical factors associated with mortality in subjects with nonalcoholic fatty liver diseaseMunkhzul Otgonsuren, Maria Stepanova, Lynn Gerber, et al.
Pageof 25

Showing results (31-40 of 242) with videos related to

Sort By:
Pageof 25
Biophysical Journal|November 13, 2007
Conformational analysis of the carboxy-terminal tails of human beta-tubulin isotypesTyler Luchko, J Torin Huzil, Maria Stepanova, et al.
Plos One|November 24, 2011
Effects of temperature on the p53-DNA binding interactions and their dynamical behavior: comparing the wild type to the R248Q mutantKhaled Barakat, Bilkiss B Issack, Maria Stepanova, et al.
JHEP Reports : Innovation in Hepatology|February 21, 2025
Validation of the Chronic Liver Disease Questionnaire for MASH (CLDQ-MASH)Zobair M Younossi, Maria Stepanova, Issah Younossi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 31, 2012
In-hospital mortality and economic burden associated with hepatic encephalopathy in the United States from 2005 to 2009Maria Stepanova, Alita Mishra, Chapy Venkatesan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 15, 2019
Validation of Chronic Liver Disease Questionnaire for Nonalcoholic Steatohepatitis in Patients With Biopsy-Proven Nonalcoholic SteatohepatitisZobair M Younossi, Maria Stepanova, Issah Younossi, et al.
Clinical and Translational Gastroenterology|May 13, 2024
Validation of a Primary Biliary Cholangitis-Specific Version of Chronic Liver Disease Questionnaire: CLDQ-PBCZobair M Younossi, Maria Stepanova, Issah Younossi, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 14, 2018
Prediction of Health Utility Scores in Patients with Chronic Hepatitis C Using the Chronic Liver Disease Questionnaire-Hepatitis C Version (CLDQ-HCV)Maria Stepanova, Issah Younossi, Andrei Racila, et al.
Journal of the American Geriatrics Society|January 31, 2016
Patient-Reported Outcomes of Elderly Adults with Chronic Hepatitis C Treated with Interferon- and Ribavirin-Free RegimensZobair M Younossi, Maria Stepanova, Fatema Nader, et al.
FEBS Open Bio|June 20, 2014
Molecular mechanisms in the selective basal activation of pyrabactin receptor 1: Comparative analysis of mutantsLyudmyla Dorosh, Nandhakishore Rajagopalan, Michele C Loewen, et al.
Digestive Diseases and Sciences|November 13, 2012
Anthropometric and clinical factors associated with mortality in subjects with nonalcoholic fatty liver diseaseMunkhzul Otgonsuren, Maria Stepanova, Lynn Gerber, et al.
Pageof 25